GeneIQ

GeneIQ is a molecular diagnostics laboratory specializing in pharmacogenomic (PGx) testing. PGx testing determines how an individual will metabolize medications based on their DNA. GeneIQs comprehensive panel of 35 genes covers a wide array of specialties including addiction, cardiology, diabetes, gastroenterology, neurology, oncology, orthopedics, pain management, psychiatry, and rheumatology. We combine the expertise of an outstanding laboratory team combined with a world renowned scientific team. Our robust process and state of the art instrument methodology ensures expedited delivery of results and the highest level of patient support

Pharmacogenetics,addiction,cardiology,diabetes,gastroenterology,neurology,orthopedics,pain,psychiatry,rheumatology,#pcr,#pharmacogenomics,covid 19,anesthesia,nexgen sequencing,pgx,cgx,rpp,coronatesting,illumina nextseq,quant studio 12,long term care,and assisted living

Geneiq operates in the Medical and diagnostic laboratories industry.

Geneiq's revenue is 11m - 100m

Geneiq has 11 - 50 employees.